| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Common Stock | Options Exercise | $548K | +11K | +18.33% | $50.00 | 70.8K | Aug 7, 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | -$234K | -2.33K | -3.29% | $100.39 | 68.5K | Aug 7, 2024 | Direct | F1 |
| transaction | CBT | Common Stock | Sale | -$102K | -1K | -1.46% | $101.72 | 67.5K | Aug 7, 2024 | Direct | F2 |
| transaction | CBT | Common Stock | Sale | -$82.3K | -800 | -1.19% | $102.83 | 66.7K | Aug 7, 2024 | Direct | F3 |
| transaction | CBT | Common Stock | Sale | -$2.69K | -26 | -0.04% | $103.41 | 66.6K | Aug 7, 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | -$461K | -4.67K | -7.01% | $98.64 | 62K | Aug 7, 2024 | Direct | F4 |
| transaction | CBT | Common Stock | Sale | -$213K | -2.14K | -3.46% | $99.56 | 59.8K | Aug 7, 2024 | Direct | F5 |
| transaction | CBT | Common Stock | Options Exercise | $618K | +12.3K | +20.58% | $50.23 | 72.1K | Aug 7, 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | -$269K | -2.68K | -3.71% | $100.45 | 69.4K | Aug 7, 2024 | Direct | F6 |
| transaction | CBT | Common Stock | Sale | -$107K | -1.05K | -1.51% | $101.63 | 68.4K | Aug 7, 2024 | Direct | F7 |
| transaction | CBT | Common Stock | Sale | -$87.1K | -848 | -1.24% | $102.77 | 67.6K | Aug 7, 2024 | Direct | F8 |
| transaction | CBT | Common Stock | Sale | -$20.6K | -200 | -0.3% | $103.23 | 67.4K | Aug 7, 2024 | Direct | |
| transaction | CBT | Common Stock | Sale | -$561K | -5.69K | -8.44% | $98.62 | 61.7K | Aug 7, 2024 | Direct | F9 |
| transaction | CBT | Common Stock | Sale | -$184K | -1.85K | -3% | $99.69 | 59.8K | Aug 7, 2024 | Direct | F5 |
| holding | CBT | Common Stock | 1.61 | Aug 7, 2024 | Through the Trustee for the Corporation's 401(k) Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -11K | -46.25% | $0.00 | 12.7K | Aug 7, 2024 | Common Stock | 11K | $50.00 | Direct | F10 |
| transaction | CBT | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -12.3K | -45.53% | $0.00 | 14.7K | Aug 7, 2024 | Common Stock | 12.3K | $50.23 | Direct | F11 |
| Id | Content |
|---|---|
| F1 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.030 to $100.960, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F2 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.250 to $102.0625, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.330 to $103.220, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F4 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.970, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F5 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $99.020 to $99.970, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F6 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $100.030 to $100.990, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F7 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $101.150 to $102.0675, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F8 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $102.150 to $103.010, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F9 | The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.950, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price. |
| F10 | 23,710 shares were subject to the option. The option vested over a three year period as follows: 30% on November 9, 2019, 30% on November 9, 2020 and 40% on November 9, 2021. |
| F11 | 27,036 shares were subject to the option. The option vested over a three year period as follows: 30% on November 8, 2020, 30% on November 8, 2021 and 40% on November 8, 2022. |